. Author manuscript; available in PMC: 2016 Oct 24.

Published in final edited form as: Am J Nephrol. 2015 Oct 24;42(4):259–264. doi: 10.1159/000441199

Table 3.

Trait discrimination analysis results for T2D

						Covariates: age, gender, African ancestry proportion (AAs)
	SNP	N Cases^*	MAF Cases	N Controls^*	MAF Controls	P-value	Odds Ratio	95% Confidence Interval
African American T2D-only (GFR > 60 ml/min) vs population-based controls	rs1952034	496	0.089	1608	0.10	0.29^add	0.87	0.66, 1.13
	rs12431381	497	0.098	1765	0.11	0.26^add	0.86	0.67, 1.11
	rs12434215	495	0.072	1742	0.095	0.032^add	0.73	0.55, 0.97
European American T2D-only (GFR > 60 ml/min) vs population-based controls	rs1952034	620	0.53	752	0.55	0.40^add	0.93	0.79, 1.10
	rs12431381	619	0.54	746	0.57	0.12^add	0.88	0.75, 1.03
	rs12434215	620	0.55	753	0.58	0.048^add	0.85	0.72, 1.00

Sample size reflects those with complete clinical and genotypic data

MAF – minor allele frequency.